180 related articles for article (PubMed ID: 19187270)
1. c-Met signaling promotes IL-6-induced myeloma cell proliferation.
Hov H; Tian E; Holien T; Holt RU; Våtsveen TK; Fagerli UM; Waage A; Børset M; Sundan A
Eur J Haematol; 2009 Apr; 82(4):277-87. PubMed ID: 19187270
[TBL] [Abstract][Full Text] [Related]
2. A selective c-met inhibitor blocks an autocrine hepatocyte growth factor growth loop in ANBL-6 cells and prevents migration and adhesion of myeloma cells.
Hov H; Holt RU; Rø TB; Fagerli UM; Hjorth-Hansen H; Baykov V; Christensen JG; Waage A; Sundan A; Børset M
Clin Cancer Res; 2004 Oct; 10(19):6686-94. PubMed ID: 15475459
[TBL] [Abstract][Full Text] [Related]
3. Anti-c-MET Nanobody - a new potential drug in multiple myeloma treatment.
Slørdahl TS; Denayer T; Moen SH; Standal T; Børset M; Ververken C; Rø TB
Eur J Haematol; 2013 Nov; 91(5):399-410. PubMed ID: 23952536
[TBL] [Abstract][Full Text] [Related]
4. The role of IGF-1 as a major growth factor for myeloma cell lines and the prognostic relevance of the expression of its receptor.
Sprynski AC; Hose D; Caillot L; Réme T; Shaughnessy JD; Barlogie B; Seckinger A; Moreaux J; Hundemer M; Jourdan M; Meissner T; Jauch A; Mahtouk K; Kassambara A; Bertsch U; Rossi JF; Goldschmidt H; Klein B
Blood; 2009 May; 113(19):4614-26. PubMed ID: 19228610
[TBL] [Abstract][Full Text] [Related]
5. Cell surface proteoglycan syndecan-1 mediates hepatocyte growth factor binding and promotes Met signaling in multiple myeloma.
Derksen PW; Keehnen RM; Evers LM; van Oers MH; Spaargaren M; Pals ST
Blood; 2002 Feb; 99(4):1405-10. PubMed ID: 11830493
[TBL] [Abstract][Full Text] [Related]
6. HGF and IGF-1 synergize with SDF-1α in promoting migration of myeloma cells by cooperative activation of p21-activated kinase.
Rø TB; Holien T; Fagerli UM; Hov H; Misund K; Waage A; Sundan A; Holt RU; Børset M
Exp Hematol; 2013 Jul; 41(7):646-55. PubMed ID: 23499762
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of hepatocyte growth factor-induced retinal endothelial cell migration and growth.
Cai W; Rook SL; Jiang ZY; Takahara N; Aiello LP
Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1885-93. PubMed ID: 10845613
[TBL] [Abstract][Full Text] [Related]
8. Targeting c-met receptor tyrosine kinase by the DNA aptamer SL1 as a potential novel therapeutic option for myeloma.
Zhang Y; Gao H; Zhou W; Sun S; Zeng Y; Zhang H; Liang L; Xiao X; Song J; Ye M; Yang Y; Zhao J; Wang Z; Liu J
J Cell Mol Med; 2018 Dec; 22(12):5978-5990. PubMed ID: 30353654
[TBL] [Abstract][Full Text] [Related]
9. Radiation stimulates HGF receptor/c-Met expression that leads to amplifying cellular response to HGF stimulation via upregulated receptor tyrosine phosphorylation and MAP kinase activity in pancreatic cancer cells.
Qian LW; Mizumoto K; Inadome N; Nagai E; Sato N; Matsumoto K; Nakamura T; Tanaka M
Int J Cancer; 2003 May; 104(5):542-9. PubMed ID: 12594808
[TBL] [Abstract][Full Text] [Related]
10. The hepatocyte growth factor/Met pathway controls proliferation and apoptosis in multiple myeloma.
Derksen PW; de Gorter DJ; Meijer HP; Bende RJ; van Dijk M; Lokhorst HM; Bloem AC; Spaargaren M; Pals ST
Leukemia; 2003 Apr; 17(4):764-74. PubMed ID: 12682635
[TBL] [Abstract][Full Text] [Related]
11. Myeloma-derived extracellular vesicles mediate HGF/c-Met signaling in osteoblast-like cells.
Strømme O; Psonka-Antonczyk KM; Stokke BT; Sundan A; Arum CJ; Brede G
Exp Cell Res; 2019 Oct; 383(1):111490. PubMed ID: 31283912
[TBL] [Abstract][Full Text] [Related]
12. Mitogenic synergy through multilevel convergence of hepatocyte growth factor and interleukin-4 signaling pathways.
Day RM; Soon L; Breckenridge D; Bridges B; Patel BK; Wang LM; Corey SJ; Bottaro DP
Oncogene; 2002 Mar; 21(14):2201-11. PubMed ID: 11948403
[TBL] [Abstract][Full Text] [Related]
13. Synergistic effects of hepatocyte growth factor on human cord blood CD34+ progenitor cells are the result of c-met receptor expression.
Goff JP; Shields DS; Petersen BE; Zajac VF; Michalopoulos GK; Greenberger JS
Stem Cells; 1996 Sep; 14(5):592-602. PubMed ID: 8888500
[TBL] [Abstract][Full Text] [Related]
14. Targeting MET kinase with the small-molecule inhibitor amuvatinib induces cytotoxicity in primary myeloma cells and cell lines.
Phillip CJ; Zaman S; Shentu S; Balakrishnan K; Zhang J; Baladandayuthapani V; Taverna P; Redkar S; Wang M; Stellrecht CM; Gandhi V
J Hematol Oncol; 2013 Dec; 6():92. PubMed ID: 24326130
[TBL] [Abstract][Full Text] [Related]
15. Decorin is down-regulated in multiple myeloma and MGUS bone marrow plasma and inhibits HGF-induced myeloma plasma cell viability and migration.
Kristensen IB; Pedersen L; Rø TB; Christensen JH; Lyng MB; Rasmussen LM; Ditzel HJ; Børset M; Abildgaard N
Eur J Haematol; 2013 Sep; 91(3):196-200. PubMed ID: 23607294
[TBL] [Abstract][Full Text] [Related]
16. MET/HGF pathway in multiple myeloma: from diagnosis to targeted therapy?
Gambella M; Palumbo A; Rocci A
Expert Rev Mol Diagn; 2015; 15(7):881-93. PubMed ID: 25967746
[TBL] [Abstract][Full Text] [Related]
17. Signaling pathways in the induction of c-met receptor expression by its ligand scatter factor/hepatocyte growth factor in human glioblastoma.
Abounader R; Ranganathan S; Kim BY; Nichols C; Laterra J
J Neurochem; 2001 Mar; 76(5):1497-508. PubMed ID: 11238734
[TBL] [Abstract][Full Text] [Related]
18. CAF-derived HGF promotes cell proliferation and drug resistance by up-regulating the c-Met/PI3K/Akt and GRP78 signalling in ovarian cancer cells.
Deying W; Feng G; Shumei L; Hui Z; Ming L; Hongqing W
Biosci Rep; 2017 Apr; 37(2):. PubMed ID: 28258248
[TBL] [Abstract][Full Text] [Related]
19. Hepatocyte growth factor/scatter factor-induced activation of MEK and PI3K signal pathways contributes to expression of proangiogenic cytokines interleukin-8 and vascular endothelial growth factor in head and neck squamous cell carcinoma.
Dong G; Chen Z; Li ZY; Yeh NT; Bancroft CC; Van Waes C
Cancer Res; 2001 Aug; 61(15):5911-8. PubMed ID: 11479233
[TBL] [Abstract][Full Text] [Related]
20. Cross talk between c-Met and epidermal growth factor receptor during retinal pigment epithelial wound healing.
Xu KP; Yu FS
Invest Ophthalmol Vis Sci; 2007 May; 48(5):2242-8. PubMed ID: 17460286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]